Dissecting underlying mechanisms of aging
Aging is not a disease, but it is often accompanied by a complex array of chronic degenerative diseases. Sironax is committed to promoting healthier aging by targeting the underlying mechanisms of degeneration across various organs and tissues, including neuronal/axonal degeneration, muscle degeneration, epithelial cell death, neuroinflammation, and oxidative stress.
Explore our pipeline
A robust pipeline of first-in-class and best-in-class assets, including multiple clinical-stage small molecule programs and large molecule therapeutics enabled by our proprietary Brain Delivery Module (BDM) platform.
Company News
Apr. 22, 2025
Sironax Completed Phase I study for SIR2501
Mar. 31, 2025
Sironax Celebrates US Team Expansion And China IND Approvals